tiprankstipranks
Vertex Pharmaceuticals (VRTX)
NASDAQ:VRTX
US Market

Vertex Pharmaceuticals (VRTX) Financial Statements

Compare
5,952 Followers

Vertex Pharmaceuticals Financial Overview

Vertex Pharmaceuticals's market cap is currently $117.87B. The company's EPS TTM is $-2.201; its P/E ratio is ―; Vertex Pharmaceuticals is scheduled to report earnings on February 11, 2025, and the estimated EPS forecast is $4.25. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue$ 11.02B$ 9.87B$ 8.93B$ 7.57B$ 6.21B
Gross Profit$ 9.49B$ 8.61B$ 7.85B$ 6.67B$ 5.47B
Operating Income$ -232.90M$ 4.31B$ 4.31B$ 2.78B$ 2.86B
EBITDA$ 486.30M$ 4.61B$ 4.44B$ 2.92B$ 3.28B
Net Income$ -535.60M$ 3.62B$ 3.32B$ 2.34B$ 2.71B
Balance Sheet
Cash & Short-Term Investments$ 6.12B$ 11.22B$ 10.78B$ 7.52B$ 6.66B
Total Assets$ 22.53B$ 22.73B$ 18.15B$ 13.43B$ 11.75B
Total Debt$ 1.75B$ 808.40M$ 561.00M$ 556.70M$ 581.48M
Net Debt$ -2.82B$ -9.56B$ -9.94B$ -6.24B$ -5.41B
Total Liabilities$ 6.12B$ 5.15B$ 4.24B$ 3.33B$ 3.06B
Stockholders' Equity$ 16.41B$ 17.58B$ 13.91B$ 10.10B$ 8.69B
Cash Flow
Free Cash Flow$ -790.30M$ 3.28B$ 3.93B$ 2.41B$ 2.99B
Operating Cash Flow$ -492.60M$ 3.54B$ 4.13B$ 2.64B$ 3.25B
Investing Cash Flow$ -3.77B$ -3.14B$ -321.10M$ -340.90M$ 99.39M
Financing Cash Flow$ -1.49B$ -562.20M$ -67.70M$ -1.48B$ -505.28M
Currency in USD

Vertex Pharmaceuticals Earnings and Revenue History

Vertex Pharmaceuticals Debt to Assets

Vertex Pharmaceuticals Cash Flow

Vertex Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis